• Nuclear Engineering and Technology
• /
• v.52 no.5
• /
• pp.1002-1007
• /
• 2020

The purpose of the current study was to evaluate a spectrum formulation set employed to modify the neutron spectrum of D-D fusion neutrons in a IS plasma focus device using GEANT4, MCNPX2.6, and FLUKA codes. The set consists of a moderator, reflector, collimator and filters of fast neutron and gamma radiation, which placed on the path of 2.45 MeV neutron energy. The treated neutrons eliminate cancerous tissue with minimal damage to other healthy tissue in a method called neutron therapy. The system optimized for a total neutron yield of 10⁹ (n/s). The numerical results indicate that the GEANT4 code for the cubic geometry in the Beam Shaping Assembly 3 (BSA3) is the best choice for the energy of epithermal neutrons.

• Nuclear Engineering and Technology
• /
• v.41 no.4
• /
• pp.531-544
• /
• 2009

This paper is intended to provide key issues and current research outcomes on accelerator-based Boron Neutron Capture Therapy (BNCT). Accelerator-based neutron sources are efficient to provide epithermal neutron beams for BNCT; hence, much research, worldwide, has focused on the development of components crucial for its realization: neutron-producing targets and cooling equipment, beam-shaping assemblies, and treatment planning systems. Proton beams of 2.5 MeV incident on lithium target results in high yield of neutrons at relatively low energies. Cooling equipment based on submerged jet impingement and micro-channels provide for viable heat removal options. Insofar as beam-shaping assemblies are concerned, moderators containing fluorine or magnesium have the best performance in terms of neutron accumulation in the epithermal energy range during the slowing-down from the high energies. NCT_Plan and SERA systems, which are popular dose distribution analysis tools for BNCT, contain all the required features (i.e., image reconstruction, dose calculations, etc.). However, detailed studies of these systems remain to be done for accurate dose evaluation. Advanced research centered on accelerator-based BNCT is active in Korea as evidenced by the latest research at Hanyang University. There, a new target system and a beam-shaping assembly have been constructed. The performance of these components has been evaluated through comparisons of experimental measurements with simulations. In addition, a new patient-specific treatment planning system, BTPS, has been developed to calculate the deposited dose and radiation flux in human tissue. It is based on MCNPX, and it facilitates BNCT efficient planning based via a user-friendly Graphical User Interface (GUI).

• Nuclear Engineering and Technology
• /
• v.54 no.8
• /
• pp.2999-3005
• /
• 2022

The new experimental setup has been built at the 11b channel of the IBR-2 research reactor at FLNP, JINR, to study the elemental composition of samples by registration of prompt gamma emission during thermal neutron capture. The setup consists of a curved mirror neutron guide and a radiation-resistant HPGe high-purity germanium detector. The detector is surrounded by lead shielding to suppress the natural background gamma level. The sample is placed in a vacuum channel and surrounded by a LiF shield to suppress the gamma background generated by scattered neutrons. This work presents characteristics of the experimental setup. An example of hydrogen concentration determining in a diamond powder made by detonation synthesis is given and on its basis, the sensitivity of the setup is calculated being ~4 ㎍.

• Nuclear Engineering and Technology
• /
• v.55 no.7
• /
• pp.2419-2431
• /
• 2023

Experiments related to Boron Neutron Capture Therapy (BNCT) accomplished at the Institute of Nuclear Techniques (INT), Budapest University of Technology and Economics (TUB) are presented. Relevant investigations are required before designing BNCT for vivo applications. Samples of relevant boron compounds (H₃BO₃, BDTPA) usually employed in BNCT were investigated with neutron beam. Channel #5 in the research reactor (100 kW) of INT-TUB provides the neutron beam. Boron samples are mounted on a carrier for neutron irradiation. The particle attenuation of several carrier materials was investigated, and the one with the lowest attenuation was selected. The effects of boron compound type, mass, and compound phase state were also investigated. To detect the emitted charged particles, a traditional ZnS(Ag) detector was employed. The neutron beam's interaction with the detector-detecting layer is investigated. Graphite (as a moderator) was employed to change the neutron beam's characteristics. The fast neutron beam was also thermalized by placing a portable fast neutron source in a paraffin container and irradiating the H₃BO₃. The obtained results suggest that the direct measurement approach appears to be insufficiently sensitive for determining the radiation dose committed by the Alpha particles from the ¹⁰B (n,α) reaction. As a result, a new approach must be used.

• Journal of Radiopharmaceuticals and Molecular Probes
• /
• v.7 no.1
• /
• pp.3-10
• /
• 2021

For successful boron neutron caputre therapy, it is essential to develop a boron drug with a selective accumulation capacity for tumors. In particular, in order to apply boron neutron caputre therapy to brain tumors, drugs with good blood-brain barrier penetration are required. In this study, two low-molecular-weight boron compounds were introduced as brain tumor boron neutron caputre therapy drugs, and their physical and biological efficacy were evaluated. Among them, B2 showed good blood-brain barrier permeability and a high brain/blood ratio. From these results, it is expected that B2 can be used as a useful boron drug for boron neutron caputre therapy in brain tumors.

• Nuclear Engineering and Technology
• /
• v.55 no.7
• /
• pp.2712-2722
• /
• 2023

For an accurate and efficient time-dependent Monte Carlo (TDMC) neutron transport analysis, several advanced methods are newly developed and implemented in the Seoul National University Monte Carlo code, McCARD. For an efficient control of the neutron population, a dynamic weight window method is devised to adjust the weight bounds of the implicit capture in the time bin-by-bin TDMC simulations. A moving geometry module is developed to model a continuous insertion or withdrawal of a control rod. Especially, the history-based batch method for the TDMC calculations is developed to predict the unbiased variance of a bin-wise mean estimate. The developed methods are verified for three-dimensional problems in the C5G7-TD benchmark, showing good agreements with results from a deterministic neutron transport analysis code, nTRACER, within the statistical uncertainty bounds. In addition, the TDMC analysis capability implemented in McCARD is demonstrated to search the optimum detector positions for the pulsed-neutron-source experiments in the Kyoto University Critical Assembly and AGN201K.

• Progress in Medical Physics
• /
• v.18 no.2
• /
• pp.87-92
• /
• 2007

A thermal neutron beam facility utilizing a typical tangential beam port for Neutron Capture Therapy was installed at the HANARO, 30 MW multi-purpose research reactor. Mixed beams with different physical characteristics and relative biological effectiveness would be emitted from the BNCT irradiation facility, so a quantitative analysis of each component of the mixed beams should be performed to determine the accurate delivered dose. Thus, various techniques were applied including the use of activation foils, TLDs and ionization chambers. All the dose measurements were perform ed with the water phantom filled with distilled water. The results of the measurement were compared with MCNP4B calculation. The thermal neutron fluxes were $1.02E9n/cm^2{\cdot}s\;and\;6.07E8n/cm^2{\cdot}s$ at 10 and 20 mm depth respectively, and the fast neutron dose rate was insignificant as 0.11 Gy/hr at 10 mm depth in water The gamma-ray dose rate was 5.10 Gy/hr at 20 mm depth in water Good agreement within 5%, has been obtained between the measured dose and the calculated dose using MCNP for neutron and gamma component and discrepancy with 14% for fast neutron flux Considering the difficulty of neutron detection, the current study support the reliability of these results and confirmed the suitability of the thermal neutron beam as a dosimetric data for BNCT clinical trials.

• Proceedings of the Korean Nuclear Society Conference
• /
• 1998.10a
• /
• pp.354-354
• /
• 1998

• Proceedings of the Korean Nuclear Society Conference
• /
• 1999.10a
• /
• pp.68-68
• /
• 1999

• Proceedings of the Korean Nuclear Society Conference
• /
• 2002.05a
• /
• pp.60-60
• /
• 2002